Introduction
The central nervous system (CNS) 1 lacks fully developed lymphoid tissue and is isolated from the immune system by the blood brain barrier (BBB) (reviewed in references 1-4). These circumstances require an efficient means of recruiting inflammatory cells into the CNS to respond to pathogens and other noxious stimuli (5, 6 ). The precise molecular determinants of CNS leukocyte entry are unknown. The general mechanism of inflammatory cell recuitment is likely to be relevant to the pathogenesis of diverse CNS disorders such as brain trauma, cerebral infarction, multiple sclerosis (MS) and AIDS-dementia complex. Leukocyte extravasation is a feature of diverse processes including inflammation, lymphocyte recirculation, and developmental organ colonization with leukocytes (7, 8) . The events that govern leukocyte extravasation are in large measure conserved among these processes, and involve sequential interactions between leukocyte and endothelium via ligand-receptor pairs. Three classes of interacting molecules have been identified: selectin-carbohydrate, chemoattractant-receptor, and integrin-immunoglobulin (Ig) superfamily member (7, 8) . Selectin-carbohydrate interactions initiate leukocyte rolling along the vessel wall. Stronger adhesion is mediated by activated leukocyte integrins and Ig superfamily members on endothelial cells.
Among the chemoattractants, chemokines, a novel family of chemoattractant cytokines (9) have been identified as important factors in leukocyte migration during inflammation [reviewed in (7, (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . Chemokines are small, inducible proteins made by a wide variety of cell types, which stimulate directional migration of specific target cells in vitro. They also play a role in enhancing leukocyte-endothelial cell interactions. Based on genetic, structural and functional considerations, chemokines are divided into ␣ -and ␤ -chemokine subfamilies; ␣ -chemokines act primarily on neutrophils, while ␤ -chemokines are relatively specific for monocytes and lymphocytes. Selective chemokine expression may thus be a general mechanism for determining the subpopulation of leukocytes which enter tissue sites of inflammation.
KC (also designated N51 in the murine system and termed N51/KC in this manuscript) is a rodent ␣ -chemokine related to the human chemokine interleukin-8 (IL-8) (20) (21) (22) (23) (24) (25) (26) . N51/KC stimulates chemotaxis specifically of neutrophils, which exit rapidly from the circulation to provide the first line of cellular defense against invading pathogens. Originally identified as a transcript induced in mitogen-stimulated fibroblasts, N51/KC has high homology to the human melanocyte growth-stimulatory activity/ gro proteins. When expressed in thymus or skin of transgenic mice, N51/KC mediated tissue-specific infiltration by mature neutrophils (27) . Intratracheal instillation of recombinant N51/KC caused neutrophil migration into rat lungs (26) . N51/KC and/or IL-8 expression has been demonstrated in pathologic conditions of lung, kidney, skin, liver and CNS, consistent with the notion that chemokines are general inflam-matory mediators (14, 15, 18, 21, (28) (29) (30) (31) (32) (33) (34) ). An N51/KC receptor has been identified as a mouse homolog of the human IL-8 B receptor (35) (36) (37) (38) .
In the CNS, neutrophils limit acute infections (39, 40) . Neutrophils are also found in noninfectious conditions such as ischemia and inflammatory demyelinating syndromes such as acute hemorrhagic leukoencephalitis and the animal model experimental autoimmune encephalomyelitis (EAE) (41) . Additionally, neutrophils are found in the cerebrospinal fluid in association with hemorrhage, tumor and MS (42, 43) . Neutrophils are potent mediators of the acute inflammatory response and may promote tissue injury in these noninfectious CNS disorders.
Chemokines have been detected in a number of CNS pathological conditions such as ischemia, EAE, trauma, and bacterial meningitis, but their role in the pathogenesis and maintenance of these processes remains to be fully clarified (44-51). Recent intriguing results indicate that neutralizing antibodies to chemokines can prevent T cell-mediated transfer of autoimmune CNS disease (52) . Further, transgenic expression of monocyte chemoattractant protein-1 (MCP-1) in the CNS of mice induced extravasation of monocytes into the perivascular space (53) . Few functional studies of neutrophil chemokine activity in the CNS have been reported. Intrathecal injection of monocyte inflammatory protein (MIP)-1 caused neutrophilic meningitis and brain edema (48) . Intraparenchymal injection of the chemokine IL-8 resulted in neutrophil margination within vessels but minimal extravasation, and no infiltration into the parenchyma (54). These results suggested that the CNS could be highly resistant to chemokine-driven neutrophil extravasation or infiltration. To study the function of N51/KC in the CNS, we established transgenic mice (MBP-N51/KC mice) expressing N51/KC under control of 1.9 kb of the MBP promoter, which has been shown to drive transgene activity uniquely in oligodendrocytes, the myelin-forming cells of the CNS (55). Fig. 1 A ) was constructed by cloning N51/KC cDNA ( ϩ 2 to ϩ 410 bp) into the XbaI-BamHI site of the plasmid pM ␤ P, a gift from Dr. R.A. Lazzarini (Mt. Sinai Medical Center, New York, NY). The pM ␤ P contains 1.9 kb of the MBP proximal promoter and enhancer which drives oligodendrocyte-specific expression in a pattern similar to endogenous MBP (55) . This plasmid provided splice and polyadenylation signals from proteolipid protein (PLP) gene including part of exon 6, intron 6, and exon 7. The transgene was isolated from the vector by NotI digestion followed by gel purification using a Quiaex kit (Qiagen Inc., Chatsworth, CA).
Methods

MBP-N51/KC transgene construction. The transgene (
Generation of transgenic mice. The isolated transgene was microinjected into eggs of [C57BL/6J ϫ DBA/2]F1 mice (Jackson Laboratories, Bar Harbor, ME) according to standard methodology, as previously described (27) . Microinjected eggs were transferred into oviducts of ICR (Sprague-Dawley) foster mothers according to published procedures (27) . Animals were kept in pathogen-free conditions. At 10 d of age, tail DNA was analyzed for the presence of transgene by polymerase chain reaction (PCR) using the following primers: 5 Ј -AGAAGACCCCACAGCAGC-3 Ј and 5 Ј -GTGAATGAG-TAGCAGCAGGT-3 Ј that amplify a 198-bp segment of the transgene. ␤ -thyroid stimulating hormone primers, previously described, served as an internal control for this reaction (27) . PCR conditions were: 95 Њ C for 60 s; 55 Њ C for 90 s; 72 Њ C for 60 s for 30 cycles (27) . Transgenic lines heterozygous for the transgene were established.
RNA analysis. RNA was extracted from tissues using RNAzol following manufacturer's instructions (Cinna/Biotecx, Houston, TX).
Total RNA (10 g) was denatured and blotted onto Hybond-N membrane (Amersham Corp., Arlington Hts., IL). A 312-bp fragment of the murine N51/KC cDNA was radiolabeled using a random-priming DNA labeling kit (Amersham) and was used as a probe in dot-blot experiments (23) .
Western blot. Brains from transgenic and control mice were homogenized in 2 ml of 10 mM Tris-HCl pH 7.4, 5 mM EDTA, 0.2 M NaCl, 1% Triton X-100 and 1 mM phenylmethylsulfonylfluoride (Sigma Chemical Co., St. Louis, MO). After centrifugation, protein content of the supernatant was determined and 75 g of total protein Western blot analysis of N51/ KC in the CNS of transgenic mice showed that N51/KC was present in brains of tg mice only. Soluble protein was prepared from brains of normal control (C) and transgenic (T) mice at age 3 wk and subjected to Western blot analysis with polyclonal antibodies to N51/KC, as described in Methods. Recombinant N51/KC was co-electrophoresed as a positive control (ϩ). Migration of molecular size markers is shown at left. Antibodies to lactic dehydrogenase (LDH) were used to demonstrate equal loading of protein from control and transgenic brain samples. (C) Time course of N51/KC RNA accumulation in CNS of tg mice followed the previously reported pattern of endogenous MBP expression. RNA was prepared from brains of tg mice of varying ages (in days) as indicated at top. 10 g of total RNA was analyzed by high-stringency dot-blot hybridization for N51/KC transcripts as described in Methods. N51/KC mRNA was first detected at 11 d; N51/ KC expression peaked at 18-24 d, and declined progressively thereafter to persistent low levels after 59 days. Parallel samples were analyzed for 18 s ribosomal RNA, to ensure equal content of hybridizable RNA in all samples, as shown at bottom. (D) MBP-driven N51/ KC expression is limited to the CNS. At 3 wk of age, RNA was prepared from CNS tissues (cerebellum, cerebrum and brainstem) and other organs as indicated. By dot-blot hybridization, N51/KC transcripts are detected only in CNS tissues.
per extract was separated by polyacrylamide gel electrophoresis and blotted onto Hybond ECL membrane (Amersham) using a semi-dry procedure. N51/KC was detected using a monospecific antibody, as previously described (27) .
Histological and immunohistochemical examination of CNS tissues. After cardiac perfusion of mice with 4% paraformaldehyde solution in 0.1 M phosphate buffer, brains and spinal cords were dissected and immersed overnight in cryoprotection solution (20% glycerol, 0.08 M Sorenson's buffer, pH 7.6). 30-m-thick coronal sections of the brain and transverse sections of the spinal cord were cut on a sliding microtome (Leica, Deerfield, IL). Tissue sections were stained with hematoxylin and eosin (H&E), cresyl violet or immunostained as free-floating sections. For immunostaining, sections were pretreated as necessary by microwaving twice for 5 min each in 10 mM sodium citrate buffer, pH 6.0, placed in 1% H 2 O 2 , 10% Triton X-100 in PBS for 30 min; blocked with 3% normal goat or rabbit serum (Sternberger Monoclonals, Baltimore, MD) in PBS for 30 min; incubated in primary antibody overnight at 4 Њ C; incubated in appropriate biotinylated secondary antibody for 30 min; immersed in avidin-biotin-horseradish peroxidase complex diluted 1 Ϻ 1000 for 1 h (Vectastain Elite ABC Kit, Vector, Burlingame, CA); stained in diaminobenzidine (0.67 mg/ ml, Sigma Chemical Co.), 0.01% H 2 O 2 in PBS; enhanced with 0.04% osmium tetroxide (Electron Microscopy Sciences, Fort Washington, PA) for 30 s and mounted in glycerol. The primary antibodies and working dilutions in PBS were as follows: rat monoclonal antimurine neutrophils (also called 7/4, 1 Ϻ 200), rat monoclonal anti-F4/80 (1 Ϻ 200) and rat monoclonal anti-murine intercellular adhesion molecule-1 (ICAM-1, 1 Ϻ 10,000) were obtained from Serotec (Washington, D.C.); goat anti-murine IgG (1 Ϻ 10,000, Vector); rat monoclonal anticommon leukocyte antigen (CLA, 1 Ϻ 200, Boehringer-Mannheim, Indianapolis, IN); rabbit polyclonal anti-bovine glial fibrillary acidic protein (GFAP, 1 Ϻ 5000; Dako, Santa Barbara, CA); rat monoclonal anti-PLP (1 Ϻ 200, Agmed, Bedford, MA); and mouse monoclonal anti-phosphorylated neurofilament (1 Ϻ 10,000, Sternberger Monoclonals). Rabbit polyclonal KC antibodies (1 Ϻ 10,000) and recombinant bacterially produced KC were generously provided by Drs. Craig Gerard and Carmen Bozic (Children's Hospital Medical Center, Boston, MA) (25) . For preabsorption of the KC antiserum, purified bacterially produced KC (0.04 mg/ml) was incubated with a 1 Ϻ 10 dilution of the antibodies at room temperature for one hour, then diluted to final 1 Ϻ 10,000 for immunohistochemistry. Biotinylated secondary antibodies (Vector) were used at a dilution of 1 Ϻ 500.
Electron microscopy. Animals were perfused with McDowellTrump solution in 0.1 M phosphate buffer (53) . After post-fixation, tissues were dehydrated in a graded series of methanol baths and embedded in epoxy resin. 1-m-thick sections were cut from the epoxyembedded material, stained with toluidine blue and delineated for ultrathin sections. Ultrathin sections of brain, ‫ف‬ 60-90 nm thick, were mounted on copper grids, stained with uranyl acetate and lead citrate and examined with a Zeiss 10C transmission electron microscope.
Results
Generation of transgenic mice and determination of transgene expression.
After microinjection experiments, we determined the presence of transgene by PCR analysis of tail DNA. Western blot showed the CNS of transgenic mice contained N51/ KC ( Fig. 1 B ) . Transgene mRNA expression followed the developmentally-regulated pattern of endogenous MBP, peaking at 2-3 wk of age, then declining to low levels characteristically seen in adult brain (55) (Fig. 1 C ) . Dot-blot analysis of N51/KC mRNA levels in kidney, liver, heart, intestine, spleen, thymus, lung, cerebellum, cerebrum and brain stem indicated that transgene expression was limited to the CNS, consistent with previous studies of gene expression directed by the 1.9-kb MBP promoter (55) (Fig. 1 D ) . Three of three founder mice and 2 of 6 transgenic lines had abundant neutrophil infiltration in the CNS at 3 wk of age. Infiltrates were readily detected at all levels of the neuraxis, including cerebrum, brain stem, and spinal cord (not shown).
Progressive neurological dysfunction in MBP-N51/KC tg mice. MBP-N51/KC tg mice did not exhibit detectable behavioral phenotype at 3 weeks, the time of maximal chemokine expression and gross, focal CNS neutrophilia (Figs. 2 and 3 A ) . Thereafter, however, tg mice of the high-expressor line 17 exhibited grossly decreased life span. Of 182 mice from line 17, 68 (37%) were found dead at ages Ͻ 350 d. 22 of these 68 mice (32%) died at age Ͻ 100 d; 17 mice (25%) died between 100 and 150 d, 21 mice (31%) died between 151-250 d and 8 mice (12%) died between 251-350 d. 26 (38%) of 68 mice later found dead exhibited a syndrome of progressive neurological dysfunction during the premortem period. Initial signs of neurological dysfunction invariably appeared in affected mice after 40 d, well beyond the peak of chemokine expression, and consisted of slowing of the righting reflex. With time, circling behavior and clumsiness became evident in the absence of prominent weakness. Spontaneous fine motor behaviors of the forepaws were unimpaired, arguing against pyramidal tract dysfunction. Affected mice subsequently developed increased rigidity of hindlimbs and tail and profound truncal instability with striking in- Figure 2 . Neutrophil infiltration of the CNS of N51/KC tg mice is evident at 3 wk of age. Dense perivascular (arrows) and parenchymal (arrowheads) infiltration by mature neutrophils displaying characteristic lobulated nuclei and eosinophilic cytoplasm is evident in this section of brain (H&E; ϫ360).
ability to maintain upright posture with the head extended (as towards water source). The animals died in an emaciated state, probably because of inability to reach food and water, as extraneural pathologic abnormalities detected at necropsy were limited to wasting and occasional mild myeloid hyperplasia.
The median duration of unequivocal symptoms before death was 9 d (range 2-154) with a mean of 34 Ϯ 48 d (standard deviation). Mice that died before 100 d were less likely (affected mice ϭ 4/22; 18%) to exhibit symptoms than those dying between 100-250 d (14/38; 38%). Mice dying after 250 d were highly likely to evidence frank neurological impairment (7/8; 87.5%). 114 mice from line 17 remain alive, 15 of which (13%) are Ͼ 350 d of age, while 54 (47%) are 250-350 d. 13 (11%) surviving mice have recently developed typical neurological impairment; only 1 of 13 remains alive with neurological symptoms after more than 8 wk.
Neuropathological analysis of MBP-N51/KC tg mice. Serial sections of CNS tissues from two transgenic lines, designated line 17 and line 62, were examined and compared with samples from non-tg mice of the background strain. Line 62 had modest neutrophil infiltration and similar but milder histological changes compared to line 17, correlating with lower transgene expression. Detailed studies were focused on line 17, which had the most pronounced changes. CNS tissues of line 17 mice were subjected to detailed histological and immunohistochemical examination at ages 3 wk ( n ϭ 3), 41 d ( n ϭ 1), 68 d ( n ϭ 1), 101 d ( n ϭ 1), 122 d ( n ϭ 1), 137 d ( n ϭ 2) and 179 d ( n ϭ 2). All mice examined after the first three weeks had demonstrated neurological symptoms before sacrifice.
Neutrophil infiltration of CNS tissues. In MBP-N51/KC tg mice, H&E staining at three weeks of age revealed sheets of mature neutrophils in the CNS parenchyma (Fig. 2) . Immunostaining with murine neutrophil-specific monoclonal antibody 7/4 confirmed the presence of neutrophils lining the ventricles, blood vessels and leptomeninges, and focal granulocytic infiltrates throughout the CNS parenchyma (Fig. 3 A ) . Compara- ble CNS tissues from the nontransgenic background strain contained rare neutrophils within blood vessels (data not shown). In brains of older tg mice (41-179 d), a progressively more diffuse and widespread pattern of infiltration by mature neutrophils was revealed by 7⁄4 staining (Fig. 3 B ) . Gross and microscopic examination of tg brains showed no signs of tissue edema or hyperemia at any age. N51/KC, detected by immunohistochemistry as punctate cytoplasmic staining, was concentrated in white matter containing myelinated axons at all ages examined, consistent with production of N51/KC by oligodendrocytes (Fig. 3 C ) . Specificity of this immunostaining was documented by abolishing reactivity, through preabsorption of the antisera with recombinant N51/KC (Fig. 3 D ) .
Vascular alterations. In 3-wk-old mice, medium-sized veins demonstrated exuberant cuffing with neutrophils within the perivascular space or infiltrating into the parenchyma (Figs. 2  and 3 A ) . It was of interest to evaluate blood brain barrier (BBB) integrity, which was analyzed by staining for mouse IgG, a marker of extravasated serum proteins. In normal mouse brain IgG immunostaining was limited to areas which have no BBB, such as the choroid plexus and hypothalamus (data not shown). In tg mice, BBB breakdown was observed at sites of neutrophil infiltration into parenchyma (Fig. 4 A ) . High-magnification view of vascular sites of neutrophil extravasation showed a grossly expanded perivascular space (Fig. 4 B ) . To characterize vascular pathology further, endothelial cells were visualized by immunostaining for ICAM-1, the vascular adhesion molecule which binds CD11b/CD18 on neutrophils. ICAM-1 was highly expressed on virtually all vessels in the CNS of both background strain and tg mice, and the perivascular space was again shown to be distended in tg mice (Fig. 4, C -D) . In normal mouse brain, vessels were circumscribed by an intact barrier of astrocytic footprocesses, which aid in the maintenance of the BBB (Fig. 4 E, arrows) . In tg brain, where invading leukocytes remained confined in the perivascular space, this girdle of astrocyte footprocesses was maintained (Fig. 4 F, arrows) . Near adjacent vessels in these tg brains, neutrophil entry into parenchyma could be seen; at these sites, vessels demonstrated a disrupted astrocytic barrier and surrounding astrocyte activation (Fig. 4 F, arrowheads) .
Fate of infiltrating neutrophils. It was of interest to evaluate the fate of neutrophils that infiltrated the CNS of MBP-N51/ KC mice. In brains of tg mice of all ages, neutrophils with degradative changes including eosinophilic cytoplasm, nuclear pyknosis and karyolysis were readily detected (data not shown). Ultrastructurally, neutrophils with condensed nuclear chromatin, abundant lysosomal, and glycogen granules in the cytoplasm and intact cell membrane were observed, consistent with apoptotic cell death (Fig. 5 A) . Similar cells were found engulfed by macrophages, suggesting the neutrophils remained quiescent until undergoing apoptosis and phagocytosis (Fig. 5  B) . These apoptotic cells corresponded with pyknotic forms that were heavily immunoreactive with antibodies to CLA (an isoform of CD45 that serves as a panleukocyte marker (Fig. 6,  E and G) . Apoptotic neutrophils could be detected in close proximity to morphologically intact neurons. No ultrastructural indication of neutrophil degranulation was observed (Fig.  5 A) . These observations suggested that neutrophils in CNS tissues of tg mice remained quiescent. Attempts to activate the neutrophils in asymptomatic tg mice at 3 wk of age with intraperitoneal lipopolysaccharide (n ϭ 6) had no discernible effect.
Infiltrating neutrophils incite local glial activation. The microglial reaction to this tg-induced neutrophil infiltration was analyzed by comparative immunostaining for 7⁄4 (which labels neutrophils) CLA (which labels neutrophils and weakly detects hematogenous macrophages and microglia) and F4/80 (expressed only by macrophages and microglia). These analyses revealed focal microglial reaction in regions of neutrophil infiltration in younger mice (compare Figs. 3, A and B ; see also Fig. 6, D and E) . With advancing age, microglial activation was progressively more widespread and intense throughout the CNS, as neutrophil infiltration became diffuse (Figs. 3, B and  6, C, F and G) . In older mice, reactive microglia were grossly enlarged with remarkable process extension (Fig. 6, F and G) .
Close apposition between pyknotic neutrophils and activated microglia was observed, using CLA immunostaining that labeled both cell populations (Fig. 6 G) . Many macrophage/microglia appeared to be phagocytizing apoptotic neutrophils (Fig. 6, D-G) . By ultrastructural analysis, macrophages contained remnants of phagocytized neutrophils, as indicated by angular crystalloid material (Fig. 5 B) . These profiles resembled those observed previously in tg mice with thymus-specific N51/KC expression (27) .
Astrocytic reaction was detected by immunoreactivity for GFAP, a specific astrocyte marker (56, 57) . Reactive astrocytosis in 3-wk-old mice was focal, and confined to regions of intense neutrophil infiltration (Fig. 7 B) . In older mice with neurological dysfunction and widespread microglial activation, the astrocytic reaction was diffuse and remarkably intense (Fig. 7 C) .
Myelination in tg mice. Neurological dysfunction in MBP-N51/KC tg mice could potentially be explained by dysmyelination, caused by programming oligodendroglia to express exogenous gene products. Such dysmyelination has complicated the interpretation of previous experiments in which the MBP promoter was used to direct the expression of cell-surface transgene products (58, 59) . Immunostaining with antibodies to myelin PLP revealed intact myelin sheaths (Fig. 8 A) . Rarely, mild mechanical displacement of myelinated fibers was detected, in foci of massive neutrophil infiltration in younger MBP-N51/KC tg mice (Fig. 8 B) . Immunostaining of phosphorylated neurofilaments indicated the structural integrity of myelinated nerve fibers in these regions of heavy neutrophil infiltration (data not shown). In older mice, PLP immunostaining revealed morphologically normal myelin (data not shown), despite chronic neutrophil infiltration and pronounced microglial and astrocytic reaction. Neurons in tg mice. The motor cortex, basal ganglia, cerebellum, and spinal cord were carefully examined by light microscopy, given the prominent motor abnormalities that were observed in tg mice. H&E stain of CNS tissues revealed normal distribution and appearance of neurons at all ages in the cerebral and cerebellar cortex, basal ganglia and spinal cord, compared to age-matched healthy controls (data not shown). Moreover, cresyl violet staining of Nissl substance, a general marker of neuronal metabolic activity, revealed a normal pattern of staining throughout the CNS (data not shown). Finally, there was no evidence of neuronophagia.
Discussion
Generation and analysis of MBP-N51/KC tg mice. The CNS function of a neutrophil-selective chemoattractant N51/KC was addressed by constructing transgenic mice, in which chemokine expression was governed by the developmentally regulated MBP promoter and targeted to oligodendrocytes. Two striking results arose from these experiments. First, neutrophils infiltrated the CNS of these tg mice in perivascular, meningeal, and parenchymal compartments; these neutrophils remained quiescent until undergoing apoptosis and phagocytosis by macrophages/microglia. The second major finding of these studies was that neurological symptoms occurred with high frequency in highexpressor tg mice. The syndrome of pronounced ataxia led to terminal wasting, with greatly decreased life span in affected animals.
N51/KC functions as a neutrophil chemoattractant in the CNS. At three weeks of age, around the peak of transgene mRNA expression, brains of MBP-N51/KC tg mice contained sheets of mature neutrophils around ventricles, meninges, and blood vessels, from which neutrophils had infiltrated into the CNS parenchyma (Figs. 2 and 3 A) . Despite robust infiltration with neutrophils, the transgenic mice appeared behaviorally normal. The absence of tissue edema, the patchy astroglial and microglial reaction and the minimal myelin and axonal disruption suggest that N51/KC functions primarily as a neutrophil chemoattractant, without significant neutrophil-activating properties in this system. After migration into tissue in response to N51/KC, neutrophils appeared to undergo apoptosis without degranulation. These observations are consistent with in vitro studies in which recombinant N51/KC caused increased integrin CD11b/CD18 expression on neutrophils but only modest increase in respiratory burst (26) . In pathologic conditions other factors are likely to be necessary to activate fully the neutrophil functions of degranulation, respiratory burst, and cytokine secretion. In this regard, the related human neutrophil chemokines IL-8 and GRO␣ do not stimulate superoxide anion production directly, but up-regulate N-formyl peptide receptors on neutrophils and potentiate superoxide production in response to bacterial components (60) .
After the early postnatal burst of MBP-promoter-driven transgene activity, a low level of N51/KC expression stimulates persistent and diffuse neutrophil migration into the CNS parenchyma. In older MBP-N51/KC mice, immunostaining for N51/KC in oligodendroglia remained widespread, indicating ongoing promoter activity (data not shown). Others have reported that intradermal injection of the neutrophil chemoattractants C5a, FMLP and leukotriene B4 resulted in transient inflammatory cell influx while human IL-8 mediated persistent chemoattractant effect, suggesting that ␣-chemokines may express chemoattractant potential at all stages of inflammation (61) . Fig. 3 A) . Higher magnification of this region demonstrating reactive astrocytosis is seen in Fig. 4 F. ϫ16. (C) In older tg mice, intense astrocyte activation is diffuse and widespread, following the pattern of neutrophil infiltration (Fig. 3 B) and microglial activation (Fig. 5 C) . ϫ16. Fig. 7 A shows mechanical displacement of myelinated fibers (arrows) by the infiltrating neutrophils, which are visible as round, refractile cells. ϫ190.
In our previous work, oligodendroglia were programmed to express the monocyte chemokine, MCP-1, and migration of monocytes into the CNS perivascular space was observed (53) . Leukocyte infiltration of the CNS parenchyma under influence of an individual transgene product, as described in this report, is unprecedented. Expression of the inflammatory cytokine IL-6 from a CNS-specific GFAP promoter resulted in a phenotype of severe neurological impairment and multiple neuropathological alterations, including inflammatory invasion by multiple subtypes of leukocytes (62) .
MBP-N51/KC transgenic mice are a model of neutrophil recruitment into the CNS. Leukocyte migration into the CNS involves a complex set of interactions between at least three activated cell types: leukocytes, cerebrovascular endothelial cells and resident CNS neuroepithelial cells (2, 6-8, 11, 16, 63) . Multiple steps comprise this process of extravasation; these include leukocyte-endothelial interaction, leukocyte cytoskeletal reorganization, release of proteolytic enzymes (by leukocytes and CNS cells), BBB disruption and migration of leukocytes along chemoattractant gradients (64) . During inflammation in vivo, mechanistic analysis is complicated by the diverse secreted products produced by multiple cell types.
In MBP-N51/KC tg mice, the chemokine transgene product was generated by oligodendroglia within white matter tracts and orchestrated multiple events required to attract a subpopulation of leukocytes from vasculature to CNS parenchyma (Fig. 3 C) . MBP-N51/KC mice therefore represent a potent and unique model for addressing the mechanism of target-selective leukocyte recruitment into the CNS. This system can be used to determine the proximate target cell for CNS N51/KC action, as endothelial-cell expression of the putative N51/KC receptor, the IL-8RB murine orthologue, has not been described. The adhesion molecules that are responsible for neutrophil recruitment to CNS tissues can also be investigated. Intercellular adhesion molecule-1 (ICAM-1) was expressed on the endothelial luminal surface of virtually all vessels in CNS tissues of both normal and tg mice, suggesting that its presence may be essential but is not sufficient for neutrophil extravasation Fig. 4, C and D) .
Neutrophil chemokines are likely inflammatory mediators in CNS disorders. Studies of several pathologic conditions of the CNS have tightly linked ␣-chemokine expression to leukocyte invasion. In a stroke model, mRNA of N51/KC and the highly homologous cytokine-induced neutrophil chemoattractant (CINC) were transiently induced in ischemic CNS tissue just prior to neutrophil invasion (46) . Similar correlation was obtained using an immunoassay for CINC protein in focal CNS ischemia-reperfusion injury (47) . The lag between chemokine expression and neutrophil infiltration suggested resident CNS cells were the source of the chemokine. CNS expression of N51/KC and other chemokines correlated with onset of histologic inflammation and clinical signs in acute EAE, a model for immune-mediated inflammation (65) . The functional data presented here strongly support the role of ␣-chemokines in vivo as chemoattractants and inflammatory mediators in the CNS.
Progressive neurologic dysfunction in MBP-N51/KC tg mice. Unexpectedly, a high proportion of line 17 MBP-N51/ KC tg mice developed neurological impairment. Symptoms took the form of a stereotyped progressive syndrome, comprised primarily of truncal ataxia with postural instability, clumsiness and rigidity without weakness. Transgenic mice demonstrated decreased life span, probably because of neurological symptoms that resulted in impaired nutrition and gave rise to a terminal wasting syndrome. Neuropathological examination of affected mice revealed histologic evidence of chronic neutrophil infiltration, advancing microglial and astroglial reaction and apoptosis of neutrophils but no significant damage to neurons, myelin or axons. Based on these findings, one can exclude dysmyelination as a trivial explanation for neurological symptoms in these MBP-N51/KC tg mice (58, 59) . Purkinje cells, the CNS component most frequently affected in disorders that cause cerebellar dysfunction and ataxia, appeared morphologically normal (data not shown). Interestingly, a syndrome of ataxia and inanition occurred in tg mice that expressed antisense IL-3 RNA (66) . The CNS of these mice was grossly unremarkable. Transgene expression in brains was documented but not assigned a cellular source. IL-3 had been previously shown to have trophic function for central cholinergic neurons, but observations made in the IL-3 antisense mice indicates that tg manipulations can potentially disclose unanticipated roles of these pleiotropic products (67) .
Several potential explanations for the neurological syndrome in these mice can be advanced, based on our data and recent research reports (68) . The neurological syndrome seems unlikely to be consequent to acute neuronal toxicity of N51/KC gene product, as mice were completely asymptomatic at the time of peak chemokine production. It also seems improbable that toxic products of activated neutrophils brought about neural dysfunction in the CNS of MBP-N51/KC tg mice, as evidence of neutrophil degranulation was lacking; furthermore, injection of tg mice with neutrophil-activating agents such as lipopolysaccharide produced no evident clinical effect.
Microglial and astroglial reaction was the most salient pathological alteration in the CNS of affected tg mice (Figs. 6  and 7 ). The intensity of glial reaction rose steadily with age, spreading to involve the cortex extensively, in parallel with the increasing incidence of frank neurological symptoms (compare Figs. 6, B and C, and 7, B and C). These observations suggest that the activation of microglia and/or astroglia by neutrophils or chemokine could lead to expression of factors that might impair neural function. Microglial reaction was particularly pronounced, and appeared to be stimulated in part by contact with apoptotic neutrophils, making the microglial cell population an attractive candidate for the mediator of neurological symptoms in MBP-N51/KC tg mice. In regions of abundant neutrophil infiltration of the parenchyma, BBB disruption could be documented (Fig. 4 A) , indicating that exposure to serum proteins might also be pertinent for neural dysfunction in MBP-N51/KC tg mice, as recently proposed for AIDSdementia complex (69).
Recent reports indicate that the human CNS contains multiple populations of projection neurons that are immunoreactive with antibodies to two chemokine receptors: the IL-8 B receptor and the Duffy antigen receptor for chemokines (DARC) (70) . Furthermore, cerebellar membrane preparations bind the melanocyte growth stimulatory activity (MGSA) chemokine with the characteristic affinity of the DARC receptor species (70) . These intriguing observations may help to clarify previous reports regarding biological responses to IL-8 by cultured hippocampal neurons (71). Taken in this context, our current findings prompt the speculation that neurological symptoms in MBP-N51/KC tg mice could be explained in part by direct receptor-mediated effects of continuous chemokine exposure on CNS neurons, either by chronic agonist action or by receptor desensitization (11, 36, 72, 73) . It will be important to distinguish among these various potential mechanisms of neural dysfunction in MBP-N51/KC tg mice, to assist in the design of therapies that safely and effectively modulate CNS chemokine action (68, 74) .
